What is growth equity?

Growth equity is minority or large-minority private equity investment in companies that have established product-market fit, typically between €5M and €50M ARR for B2B SaaS. The instrument differs from venture capital (earlier stage, power-law return model) and from buy-out private equity (control transactions, leverage). Growth equity sits structurally in between: less risk than VC, less control than buy-out PE, focused on revenue-compounding rather than turnaround economics.

How does growth equity differ from venture capital?

Venture capital invests in pre-product-market-fit and Series A companies where the dominant risk is whether the product solves a real problem. Growth equity invests in companies that have already cleared product-market fit, where the dominant risk shifts to execution: scaling, operating efficiency, talent leverage. Term sheets, time horizons, and ownership structures all differ accordingly.

What is the difference between growth equity and growth-stage private equity?

Mostly nomenclature. Both refer to minority or significant-minority investments in scaling companies past product-market fit. "Growth equity" is the more common label in the US and Europe; "growth-stage private equity" is used interchangeably and slightly more in Continental European discourse. Operator-led growth equity is a distinctive sub-category where capital is paired with deployed operating capacity.

Is private equity the same as growth equity?

Private equity is the broader category that includes growth equity, buy-out PE, secondaries, infrastructure, and other strategies. Growth equity is the subset focused on minority investments in scaling companies. The differentiation matters for SaaS founders because buy-out PE pursues control and uses leverage, while growth equity is minority-friendly and equity-financed.

What is growth equity investment criteria?

The standard criteria growth-equity firms apply: ARR thresholds (typically €5M+ for institutional growth equity; lower for operator-led firms like TGC), revenue growth rate (40%+ for institutional standards), retention metrics (NRR > 110% is institutional-quality), capital efficiency (CAC payback under 24 months, ARR per FTE > €150K), and management quality (founder-led with senior leadership bench). The detail varies by firm.

Insights / Growth equity explained

By Gaute Green-StensrudPublished 8 Oct 2025Updated 8 May 2026

Growth equity, explained.

A founder’s guide to the instrument that sits between venture capital and buy-out private equity - what it is, how it’s priced, what makes a good growth-equity investment, and where operator-led growth equity fits in the European B2B SaaS ecosystem.

What growth equity is

The instrument is private capital invested in companies that have already established product-market fit, typically between €5M and €50M of annual recurring revenue for B2B SaaS (lower for operator-led firms like TGC, which begin at €0.5M ARR). It is structurally minority - firms in this category rarely take majority positions - and the return model centres on revenue compounding rather than the leverage-and-multiple-expansion playbook of buy-out PE.

The category sits between two more familiar instruments. Venture capital invests earlier (often pre-revenue), takes higher risks, and depends on power-law portfolio mathematics: a small fraction of investments need to return the entire fund. Buy-out private equity invests later (typically €15M+ EBITDA), takes control positions, and uses leverage and operational discipline to engineer returns over a defined hold. The scale-stage instrument sits between those two: less risk than VC, less control than buy-out PE, focused on companies that work and need to scale.

How growth equity differs from venture capital

Three structural differences matter for founders:

Stage. VC invests pre-product-market-fit through Series A. The scale-stage instrument invests post-product-market-fit, typically Series B or later (or directly, without a prior institutional round).
Risk model. VC accepts that most investments will return less than capital, betting on outsized winners. Scale-stage equity expects most investments to return capital with revenue compounding; the variance in outcomes is narrower.
Founder relationship. VC term sheets compound preferences and protective rights across rounds because the early-stage risk justifies it. Term sheets at this stage are typically lighter on protective provisions because the investee company is more mature.

How growth equity differs from buy-out private equity

Three structural differences matter:

Ownership. The scale-stage instrument invests as minority. Buy-out PE pursues control (50%+).
Capital structure. Scale-stage capital is equity-only or equity-led. Buy-out PE uses leverage as a primary return driver.
Hold period and exit. The scale-stage model has flexible hold; many partnerships extend beyond a typical 4–6 year fund cycle. Buy-out PE typically structures around a defined exit window.

What makes a good growth-equity investment

Five characteristics, each of which firms in this category diligence rigorously:

1. Established product-market fit

Demonstrated by NRR > 105%, logo retention > 90% in the relevant segment, and a track record of customer expansion that doesn’t depend on heavy new-logo acquisition. Investors at this stage read NRR as the single most important durability signal; sustained NRR > 115% justifies premium multiples regardless of headline growth rate.

2. Capital efficiency

Demonstrated by Rule of 40 > 40 and a clear glide path to higher operating margins. The shape of the trajectory matters as much as the level: a Rule-of-40 score moving from 35 to 50 over 18 months is more valuable than a flat-50 score over the same period.

3. Operating-leverage path

Gross margins > 70% with stable or rising trend, sales-and-marketing intensity falling as ARR grows (CAC payback shortening with scale), and ARR per FTE rising as the company adds revenue faster than headcount.

4. Management depth

Beyond the founder, the company needs a credible CTO, a head of revenue, and a finance function. Investors in this category diligence the second-line leadership carefully because the operating risk concentrates in single-person dependencies at this stage.

5. Sectoral durability

"Will this category exist in 10 years?" is a real diligence question. Vertical SaaS in healthcare, financial services, industrial software, and regulatory-driven categories typically reads better than horizontal SaaS in commodity-like categories - not because vertical is universally better, but because the category boundary is durable.

Operator-led growth equity in Europe

The European market has historically followed the US model: capital-led firms with operating-partner programmes that engage at the executive level. The operator-led variant is a structural innovation: capital paired with deployed operating capacity (full-time engineers, GTM operators, governance specialists), under a written operating thesis.

For European B2B SaaS founders - especially in the Nordics, Benelux, DACH, and the UK - this matters because the operating-capacity gap is the binding constraint at €1M–€5M ARR. Capital is available; the deployed labour to use it is the differentiator. See the platform for how TGC structures this.

Growth equity in the German Mittelstand

The German Mittelstand - mid-market companies often family-owned, technically excellent, frequently undercapitalised on the software-product side - is a natural fit for the model when paired with operating capacity. The instrument addresses the canonical Mittelstand bottleneck: capital is scarce and operating-software talent is scarcer. Native-language coverage is on /markets/germany.

Frequently asked questions

What is growth equity?: Growth equity is minority or large-minority private equity investment in companies that have established product-market fit, typically between €5M and €50M ARR for B2B SaaS. The instrument differs from venture capital (earlier stage, power-law return model) and from buy-out private equity (control transactions, leverage). Growth equity sits structurally in between: less risk than VC, less control than buy-out PE, focused on revenue-compounding rather than turnaround economics.
How does growth equity differ from venture capital?: Venture capital invests in pre-product-market-fit and Series A companies where the dominant risk is whether the product solves a real problem. Growth equity invests in companies that have already cleared product-market fit, where the dominant risk shifts to execution: scaling, operating efficiency, talent leverage. Term sheets, time horizons, and ownership structures all differ accordingly.
What makes a good growth equity investment?: Five characteristics: (1) established product-market fit demonstrated by NRR > 105%, (2) capital efficiency demonstrated by Rule of 40 > 40, (3) a credible path to operating leverage at scale (gross margins > 70%, falling sales-and-marketing intensity), (4) management depth beyond a single founder, (5) sectoral durability - does the category still exist in 10 years. Growth equity firms diligence all five.
What is the difference between growth equity and growth-stage private equity?: Mostly nomenclature. Both refer to minority or significant-minority investments in scaling companies past product-market fit. "Growth equity" is the more common label in the US and Europe; "growth-stage private equity" is used interchangeably and slightly more in Continental European discourse. Operator-led growth equity is a distinctive sub-category where capital is paired with deployed operating capacity.
Is private equity the same as growth equity?: Private equity is the broader category that includes growth equity, buy-out PE, secondaries, infrastructure, and other strategies. Growth equity is the subset focused on minority investments in scaling companies. The differentiation matters for SaaS founders because buy-out PE pursues control and uses leverage, while growth equity is minority-friendly and equity-financed.
What is growth equity investment criteria?: The standard criteria growth-equity firms apply: ARR thresholds (typically €5M+ for institutional growth equity; lower for operator-led firms like TGC), revenue growth rate (40%+ for institutional standards), retention metrics (NRR > 110% is institutional-quality), capital efficiency (CAC payback under 24 months, ARR per FTE > €150K), and management quality (founder-led with senior leadership bench). The detail varies by firm.

Talk to TGC /markets/germany